Study guide
2.1 Strengths, Doses, and Drug Classes
PTCB Medication Therapy Management Certificate Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts & Format 1.2 Eligibility, Application & Testing 1.3 Pharmacy Technician Role in MTM 1.4 Domain Weights & Study Strategy
2 Chapter 2: Medication Product Knowledge
2.1 Strengths, Doses, and Drug Classes 2.2 Dosage Forms, Routes, and Administration Instructions 2.3 Storage, Special Handling, and Duration of Therapy 2.4 Interchangeable Classes and Forms for Cost Savings
3 Chapter 3: Terminology & History Collection
3.1 Patient-Friendly Medical Terminology 3.2 Medication Allergy vs Medication Intolerance 3.3 Adherence Definitions in Medication History 3.4 Medical History Components for MTM
4 Chapter 4: Medication-Related Problems & Labs
4.1 Common Medication-Related Problems Overview 4.2 Side Effects, Adverse Drug Reactions & Allergies in MTM 4.3 Nonadherence, Affordability Barriers & Gaps in Therapy 4.4 Lab Measures & Related Medical Terms in MTM
5 Chapter 5: Adherence Calculations
5.1 Days’ Supply, Quantity, and Dose 5.2 Proportion of Days Covered (PDC) 5.3 PQA Threshold & Star Ratings Adherence Measures
6 Chapter 6: Documentation Accuracy Reviews
6.1 Personal Medication Record (PMR) Accuracy Review 6.2 MAP and CMR Documentation Accuracy 6.3 MTM Billing Fields Accuracy Checks
7 Chapter 7: Prescribing Errors & Therapy Conflicts
7.1 Types of Prescribing Errors 7.2 Inappropriate Prescribing & Duplicate Therapy 7.3 Drug Interactions & Conflicting Therapies 7.4 Impact of Prescribing Errors & Medication Problems
8 Chapter 8: High-Risk Medications in Older Adults
8.1 2023 AGS Beers Criteria: High-Risk Medications in Older Adults 8.2 STOPP/START Concepts & Anticholinergic Burden in MTM Screening 8.3 High-Alert & Narrow Therapeutic Index Awareness for MTM Tech Support
9 Chapter 9: MTM Core Elements
9.1 Purpose of MTM & Five Core Elements 9.2 Medication Therapy Review (MTR) 9.3 Personal Medication Record (PMR) 9.4 Medication-Related Action Plan (MAP)
10 Chapter 10: Intervention, Documentation & CMS Rules
10.1 Intervention, Referral & Follow-Up 10.2 MTM Documentation Standards 10.3 CMS Part D MTM Targeting Requirements
11 Chapter 11: CMR, TMR, Billing & Workflow
11.1 Comprehensive Medication Review (CMR) 11.2 Targeted Medication Review (TMR) 11.3 CPT Billing Codes for MTM (99605 / 99606 / 99607) 11.4 Workflow Prioritization, Stages & Timelines
2.1 Strengths, Doses, and Drug Classes
Key Takeaways Explain This Topic AI
Strength is the amount of active drug per unit (for example, 10 mg tablet or 5 mg/5 mL); dose is the amount the patient takes at one time or over a day.
During MTM history and MRP screening, technicians verify that the listed strength, dose, frequency, and drug class match what the patient reports taking.
Drug class knowledge helps detect therapeutic duplication (two ACE inhibitors) and gaps (no statin when indicated)—always flag clinical judgment items to the pharmacist.
Common class suffixes and stems (for example, -pril, -olol, -statin, -prazole) speed recognition but do not replace label and profile verification.
Technicians document discrepancies; pharmacists decide therapy changes, dose adjustments, and clinical interventions.
Last updated: August 2026
2.1 Strengths, Doses, and Drug Classes
Quick Answer: In MTM, the technician verifies that each medication’s strength , dose , frequency , and drug class on the profile match what the patient actually takes. Strength is how much drug is in each unit; dose is how much the patient takes. Class knowledge helps spot duplicates and gaps—but clinical substitution and dose changes are pharmacist decisions.
Domain 1 of the PTCB Medication Therapy Management Certificate expects technicians to recognize medication strengths and doses, place drugs into therapeutic classes, and use that product knowledge while building medication histories and screening for medication-related problems (MRPs). This section focuses on verification skills you will use every day in comprehensive medication reviews (CMRs), targeted medication reviews (TMRs), and personal medication record (PMR) updates.
Strength vs. Dose: Precise Definitions
Technicians sometimes use “strength” and “dose” interchangeably. In MTM documentation they are not the same:
Term Meaning Example
Strength Amount of active ingredient in one dosage unit or concentration Lisinopril 10 mg tablets; amoxicillin 400 mg/5 mL suspension
Dose Amount administered at one time (or total daily amount when stated that way) Take 20 mg (two 10 mg tablets) once daily
- Frequency / directions How often and how to take the dose Once daily in the morning; with food
- Quantity / days’ supply How much was dispensed and for how long it should last 90 tablets; 90-day supply
A profile that lists “metformin 500 mg” without directions is incomplete for MTM. The technician should clarify whether the patient takes 500 mg once daily, twice daily, or another regimen, then document what the patient reports and flag inconsistencies for the pharmacist.
Unit and concentration traps
mg vs. mcg: Levothyroxine 75 mcg is not 75 mg . A misplaced unit is a high-priority MRP flag.
mg vs. mL: Insulin and liquid antibiotics are often ordered in units or volume; confirm whether the patient measures units , mL , or marked syringe lines.
Combination products: Each component has its own strength (for example, amlodipine/valsartan 5/160 mg). Record both strengths; do not collapse the product into a single number.
Extended-release vs. immediate-release: Metformin ER 500 mg is not interchangeable with metformin IR 500 mg on a milligram-for-milligram assumption without pharmacist review of dosing and release characteristics.
How Technicians Verify Strength and Dose During MTM History
MTM history collection is more than reading the fill history. Patients may take samples, mail-order fills, medications from another pharmacy, or leftover bottles from old prescriptions. Use a systematic check:
Ask the patient to show bottles or a current list when possible; compare name, strength, and directions on the label to the claim history.
Confirm how many units they take (“How many tablets do you take each time?”), not only “Do you take your blood pressure medicine?”
Reconcile brand and generic names for the same chemical entity so the PMR does not list both as separate therapies.
Note PRN vs. scheduled use. A patient may have tramadol 50 mg “1–2 tabs every 6 hours PRN” but actually take it three times daily every day—document actual use for the pharmacist.
Record start date and intended duration when known (for example, antibiotic for 7 days vs. lifelong ACE inhibitor).
MTM technician scenario: strength mismatch
During a CMR, a patient says they take “the little white blood pressure pill, half of it in the morning.” The profile shows carvedilol 25 mg twice daily. The technician asks the patient to describe the tablet and how it is split. The patient produces a bottle labeled carvedilol 3.125 mg . The technician documents the patient-reported strength and regimen, notes the discrepancy with the claim history, and flags the pharmacist before any counseling about heart-failure dosing occurs. The technician does not advise the patient to “just take half of the 25 mg” or change the profile alone.
Drug Classes in MTM Screening
Drug class is the therapeutic category that groups medications with similar mechanisms or indications (for example, ACE inhibitors, SSRIs, HMG-CoA reductase inhibitors). Class fluency supports two core MTM tasks:
Therapeutic duplication screening: Two drugs from the same class (lisinopril + enalapril) often signal unintended duplication.
Therapy gap screening: Absence of a usually expected class for a documented condition (no antiplatelet after recent stent) is a potential MRP for pharmacist review—not an automatic order for the technician to create.
High-yield class recognition table for MTM techs
- Class Common stem / cue Example agents MTM screening note
- ACE inhibitors -pril Lisinopril, enalapril, ramipril Watch for cough complaints; duplication with another ACEI
- ARBs -sartan Losartan, valsartan Usually not combined with ACEI without specialist intent
Beta blockers -olol (many) Metoprolol, carvedilol, atenolol Confirm IR vs ER and heart-rate goals with pharmacist
Calcium channel blockers -dipine (DHPs) Amlodipine, nifedipine Non-DHPs (diltiazem, verapamil) are different subclass
- Statins -statin Atorvastatin, rosuvastatin Intensity and dose matter for CV risk discussions
- PPIs -prazole Omeprazole, pantoprazole Long duration without indication is a common TMR flag
- SSRIs Variable Sertraline, fluoxetine, escitalopram Duplication with another serotonergic agent needs review
- Biguanides Metformin family Metformin IR/ER Strength + meal timing affect adherence conversations
- SGLT2 inhibitors -flozin Empagliflozin, dapagliflozin Indication may be diabetes, HF, or CKD—document purpose
GLP-1 RAs Injectables / dual agonists Semaglutide, dulaglutide Confirm dose escalation schedule and device strength
Stems help you recognize a class quickly; they are not a substitute for reading the full drug name, strength, and indication on the label or PMR.
Linking Class Knowledge to MRP Screening
When you screen a medication list, product knowledge turns raw names into actionable flags:
Observation Possible MRP category Technician action
Lisinopril 40 mg daily + losartan 50 mg daily Potential duplication / unsafe combo Flag for pharmacist; do not stop either drug
Profile shows warfarin 5 mg; patient reports 7.5 mg Mon/Wed/Fri Dose discrepancy Document patient-reported regimen; escalate
Two bottles: Synthroid 100 mcg and levothyroxine 100 mcg Brand/generic duplication risk Reconcile to one entry after pharmacist confirms
Amoxicillin 875 mg BID listed with no stop date, filled 3 months ago Duration / unnecessary therapy Ask if course finished; flag stale antibiotic on list
Patient with diabetes on no antihyperglycemic, A1C elevated in chart Possible untreated indication Flag for pharmacist clinical review
Technician Support Role Boundaries
Product knowledge empowers technicians to collect, verify, organize, and flag . It does not authorize independent clinical substitution, dose titration, or telling a patient to stop a medicine. In every MTM workflow:
Technician: Verifies strength/dose/class data; documents patient-reported use; identifies inconsistencies; prepares materials for CMR/TMR.
Pharmacist: Interprets clinical significance, contacts prescribers, approves therapeutic alternatives, and finalizes the medication action plan (MAP).
Exam items often test whether you escalate the right problem rather than “fixing” therapy yourself. When in doubt, document clearly and involve the pharmacist.
Practical Verification Checklist
Before marking a medication entry complete on a PMR or CMR worksheet, confirm:
Drug name (generic preferred on PMR, with brand if patient recognizes only the brand).
Strength and dosage form.
Dose, route, and frequency as the patient uses them.
Indication/purpose in patient-friendly terms when known.
Prescriber and start/stop or ongoing status.
Any mismatch between claims, bottles, and patient report— flagged .
Mastering strengths, doses, and classes is the foundation for every later Domain 1 skill: terminology, history terms, MRPs, and lab-linked therapy review.